Neumora Therapeutics Newsroom

RBC Capital Maintains Neumora Therapeutics(NMRA.US) With Buy Rating, Maintains Target Price $29

Futu NewsNov 22 20:32

Analysts' Top Healthcare Picks: Neumora Therapeutics, Inc. (NMRA), Tourmaline Bio (TRML)

TipRanksNov 22 19:57

Mizuho Securities Maintains Neumora Therapeutics(NMRA.US) With Buy Rating

Futu NewsNov 14 16:32

RBC Capital Maintains Neumora Therapeutics(NMRA.US) With Buy Rating, Maintains Target Price $29

Futu NewsNov 13 20:32

H.C. Wainwright Maintains Neumora Therapeutics(NMRA.US) With Buy Rating, Maintains Target Price $30

Futu NewsNov 13 19:31

Neumora Therapeutics, Inc.: Strategic Advancements and Unique Efficacy in MDD Trials Drive Buy Rating

TipRanksNov 13 19:28

Needham Maintains Neumora Therapeutics(NMRA.US) With Buy Rating, Maintains Target Price $23

Futu NewsNov 13 18:38

Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA), ICU Medical (ICUI) and Lexicon Pharmaceuticals (LXRX)

TipRanksNov 13 18:22

Needham Reiterates Buy on Neumora Therapeutics, Maintains $23 Price Target

BenzingaNov 13 18:12

Neumora Therapeutics Analyst Ratings

BenzingaNov 13 18:10

Mizuho Securities Maintains Neumora Therapeutics(NMRA.US) With Buy Rating

Futu NewsNov 12 16:32

Mizuho Securities Remains a Buy on Neumora Therapeutics, Inc. (NMRA)

TipRanksNov 12 15:51

Neumora Therapeutics Price Target Cut to $15.00/Share From $18.00 by JP Morgan

Dow JonesNov 5 20:26

Neumora Therapeutics Analyst Ratings

BenzingaNov 5 20:17

J.P. Morgan Initiates Neumora Therapeutics(NMRA.US) With Hold Rating, Announces Target Price $15

Futu NewsNov 5 18:33

Cautious Hold on Neumora Therapeutics Amid Uncertainty in KOASTAL-1 Trial Outcomes

TipRanksNov 5 18:11

Analysts' Top Healthcare Picks: Neumora Therapeutics, Inc. (NMRA), Amylyx Pharmaceuticals Inc (AMLX)

TipRanksOct 18 18:32

Needham Maintains Neumora Therapeutics(NMRA.US) With Buy Rating, Maintains Target Price $23

Futu NewsOct 18 18:31

Neumora Therapeutics Price Target Maintained With a $23.00/Share by Needham

Dow JonesOct 18 18:16

Stifel Maintains Neumora Therapeutics(NMRA.US) With Buy Rating, Maintains Target Price $26

Futu NewsOct 11 21:33